Find clinical trials for Ovarian Cancer in Montréal, QC
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Ovarian Cancer trials near Montréal, QC, CAN:
This study is being done to answer the following question: What are the effects of a new drug or drugs on ovarian cancer? The pre-s...
Phase 2
Montreal, Quebec, Canada and 6 other locations
of olaparib maintenance monotherapy in relapsed high grade serous ovarian cancer (HGSOC) patients (including patients with primary ...
Phase 3
Montreal, Quebec, Canada and 125 other locations
be tested together for the first time in patients with recurrent ovarian, fallopian tube, or peritoneal cancer to determine the saf...
Phase 1, Phase 2
Montréal, Quebec, Canada and 8 other locations
mirvetuximab soravtansine (MIRV) in patients with platinum resistant ovarian cancer. Approximately 102 patients will be enrolled in...
Phase 1
Montréal, Quebec, Canada and 20 other locations
followed by maintenance durvalumab and bevacizumab or durvalumab, bevacizumab and olaparib in patients with newly diagnosed advanced ovarian ...
Phase 3
Montreal, Quebec, Canada and 213 other locations
the safety and efficacy of avutometinib (VS-6766) monotherapy and in combination with defactinib in subjects with recurrent Low-Grade Serous Ovarian...
Phase 2
Montréal, Canada and 46 other locations
Olaparib Monotherapy in Patients with BRCA Mutated Ovarian Cancer following First Line Platinum Based Chemotherapy....
Phase 3
Montreal, Quebec, Canada and 176 other locations
positive, recurrent platinum sensitive, high-grade epithelial ovarian, primary peritoneal, or fallopian tube cancer following 1 pri...
Phase 2
Montréal, Quebec, Canada and 70 other locations
This study will assess the safety and efficacy of avutometinib (VS-6766) in combination with defactinib versus Investigator's choice of treatments (I...
Phase 3
Montreal, Quebec, Canada and 53 other locations
A Phase 2/3 study to investigate the efficacy and safety of luveltamab tazevibulin versus IC chemotherapy in women with ovarian cancer...
Phase 2, Phase 3
Montréal, Quebec, Canada and 38 other locations
Clinical trials
Research sites
Resources
Legal